---
title: "AEGERION PHARMACEUTICALS LIMITED/UK — Ownership Dossier"
canonical: https://whiteintel.dev/entity/214b6cfc-610b-57f2-bf7a-0cd2ebfbc287
json: https://whiteintel.dev/api/public/dossier/214b6cfc-610b-57f2-bf7a-0cd2ebfbc287
identifier: sec:0001783448
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# AEGERION PHARMACEUTICALS LIMITED/UK

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001783448`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/214b6cfc-610b-57f2-bf7a-0cd2ebfbc287  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/214b6cfc-610b-57f2-bf7a-0cd2ebfbc287  

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **AEGERION PHARMACEUTICALS LIMITED/UK**. Human view: https://whiteintel.dev/entity/214b6cfc-610b-57f2-bf7a-0cd2ebfbc287 · Structured JSON: https://whiteintel.dev/api/public/dossier/214b6cfc-610b-57f2-bf7a-0cd2ebfbc287._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._